Decoy Therapeutics Inc. (DCOY) Operating margin 2016–2021
Decoy Therapeutics Inc. (DCOY) operating margin by fiscal year — reported operating income divided by reported revenue.
-696.3%FY2021 · since FY2016: -3946.5% → -696.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2021 | -696.3% | -547.5 pp |
| FY2020 | -148.8% | +89.7 pp |
| FY2019 | -238.5% | -152.2 pp |
| FY2018 | -86.3% | +2638.3 pp |
| FY2017 | -2724.6% | +1221.9 pp |
| FY2016 | -3946.5% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More DCOY financial trends
DCOY RevenueDCOY Net incomeDCOY Net marginDCOY Gross profitDCOY Gross marginDCOY Operating incomeDCOY Operating cash flowDCOY Free cash flowDCOY Capital expendituresDCOY Return on equityDCOY Stock buybacksDCOY Dividends paidDCOY Total assetsDCOY Total liabilitiesDCOY Shareholders’ equityDCOY overview →